tiprankstipranks
Immunitybio Inc (IBRX)
:IBRX
US Market

ImmunityBio (IBRX) Technical Analysis

Compare
1,278 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Immunitybio Inc’s (IBRX) Moving Averages Convergence Divergence (MACD) indicator is 0.13, suggesting Immunitybio Inc is a Sell.
Immunitybio Inc’s (IBRX) 20-Day exponential moving average is 3.34, while Immunitybio Inc’s (IBRX) share price is $3.64, making it a Buy.
Immunitybio Inc’s (IBRX) 50-Day exponential moving average is 3.38, while Immunitybio Inc’s (IBRX) share price is $3.64, making it a Buy.

ImmunityBio (IBRX) Pivot Points

Feb 21, 2025, 01:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.53
2.95
3.42
3.85
4.32
4.75
5.22
Fibonacci
2.95
3.29
3.50
3.85
4.19
4.40
4.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ImmunityBio (IBRX) Moving Averages

Feb 21, 2025, 01:17 PM
Period
Simple
Exponential
MA5
3.57Buy
3.58Buy
MA10
3.43Buy
3.47Buy
MA20
3.32Buy
3.34Buy
MA50
3.10Buy
3.38Buy
MA100
3.80Sell
3.72Sell
MA200
4.68Sell
4.43Sell
Immunitybio Inc’s (IBRX) 10-Day exponential moving average is 3.47, while Immunitybio Inc’s (IBRX) share price is $3.64, making it a Buy.
Immunitybio Inc’s (IBRX) 100-Day exponential moving average is 3.72, while Immunitybio Inc’s (IBRX) share price is $3.64, making it a Sell.
Immunitybio Inc’s (IBRX) stock price is $3.64 and Immunitybio Inc’s (IBRX) 50-day simple moving average is 3.10, creating a Buy signal.
Immunitybio Inc’s (IBRX) stock price is $3.64 and Immunitybio Inc’s (IBRX) 100-day simple moving average is 3.80, creating a Sell signal.
Immunitybio Inc’s (IBRX) stock price is $3.64 and Immunitybio Inc’s (IBRX) 200-day simple moving average is 4.68, creating a Sell signal.

ImmunityBio (IBRX) Technical Indicators

Feb 21, 2025, 01:17 PM
Name
Value
Implied Action
RSI (14)
57.33
Neutral
STOCH (9,6)
49.77
Neutral
STOCHRSI (14)
49.77
Neutral
MACD (12,26)
0.13
Sell
ADX (14)
25.14
Neutral
Williams %R
-52.50
Buy
CCI (14)
160.08
Sell
ATR (14)
0.34
-
Ultimate Oscillator
43.99
Neutral
ROC
4.90
Buy
Immunitybio Inc’s (IBRX) Relative Strength Index (RSI) is 57.33, creating a Neutral signal.
Immunitybio Inc’s (IBRX) Trend Strength Indicator (ADX) is 25.14, creating a Neutral signal.
Immunitybio Inc’s (IBRX) Commodity Channel Index (CCI) is 160.08, creating a Sell signal.
Immunitybio Inc’s (IBRX) Price Rate of Change (ROC) is 4.90, creating a Buy signal.

FAQ

Is IBRX a Buy, Hold, or Sell?
Based on IBRX’s technical indicators, IBRX is a Buy.
    What is IBRX’s RSI (14)?
    IBRX’s RSI (14) is 57.33, which suggests IBRX is a Neutral.
      What is IBRX’s MACD?
      IBRX’s MACD is 0.13, which suggests IBRX is a Sell.
        What is IBRX’s 5-day moving average?
        IBRX’s 5-day moving average is 3.57, which suggests IBRX is a Buy.
          What is IBRX’s 20-day moving average?
          IBRX 20-day moving average is 3.32, which suggests IBRX is a Buy.
            What is IBRX’s 50-day moving average?
            IBRX’s 50-day moving average is 3.10, which suggests IBRX is a Buy.
              What is IBRX’s 200-day moving average?
              IBRX’s 200-day moving average is 4.68, which suggests IBRX is a Sell.
                What is IBRX’s Williams % R (14)?
                IBRX’s Williams % R (14) is -52.50, which suggests IBRX is a Buy.
                  What is IBRX’s CCI (14)?
                  IBRX’s CCI (14) is 160.08, which suggests IBRX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis